114 related articles for article (PubMed ID: 20120019)
1. Effects of insulin-mimetic vanadyl-poly(gamma-glutamic acid) complex on diabetic rat model.
Hu R; He C; Liu J; Wu Y; Li J; Feng Z; Huang J; Xi XG; Wu Z
J Pharm Sci; 2010 Jul; 99(7):3041-7. PubMed ID: 20120019
[TBL] [Abstract][Full Text] [Related]
2. Antidiabetic activity of the orally effective vanadyl-poly (gamma-glutamic acid) complex in streptozotocin(STZ)-induced type 1 diabetic mice.
Karmaker S; Saha TK; Sakurai H
J Biomater Appl; 2008 Mar; 22(5):449-64. PubMed ID: 17494957
[TBL] [Abstract][Full Text] [Related]
3. A novel drug delivery system for type 1 diabetes: insulin-mimetic vanadyl-poly(gamma-glutamic acid) complex.
Karmaker S; Saha TK; Yoshikawa Y; Yasui H; Sakurai H
J Inorg Biochem; 2006 Sep; 100(9):1535-46. PubMed ID: 16824605
[TBL] [Abstract][Full Text] [Related]
4. Amelioration of hyperglycemia and metabolic syndromes in type 2 diabetic KKA(y) mice by poly(gamma-glutamic acid)oxovanadium(IV) complex.
Karmaker S; Saha TK; Yoshikawa Y; Sakurai H
ChemMedChem; 2007 Nov; 2(11):1607-12. PubMed ID: 17768733
[TBL] [Abstract][Full Text] [Related]
5. Anti-diabetic effects of vanadium(III, IV, V)-chlorodipicolinate complexes in streptozotocin-induced diabetic rats.
Li M; Ding W; Smee JJ; Baruah B; Willsky GR; Crans DC
Biometals; 2009 Dec; 22(6):895-905. PubMed ID: 19404749
[TBL] [Abstract][Full Text] [Related]
6. Syntheses of vanadyl and zinc(II) complexes of 1-hydroxy-4,5,6-substituted 2(1H)-pyrimidinones and their insulin-mimetic activities.
Yamaguchi M; Wakasugi K; Saito R; Adachi Y; Yoshikawa Y; Sakurai H; Katoh A
J Inorg Biochem; 2006 Feb; 100(2):260-9. PubMed ID: 16387366
[TBL] [Abstract][Full Text] [Related]
7. Anti-diabetic effects of cesium aqua (N,N'-ethylene(salicylideneiminato)-5-sulfonato) oxovanadium (IV) dihydrate in streptozotocin-induced diabetic rats.
Li M; Wei D; Ding W; Baruah B; Crans DC
Biol Trace Elem Res; 2008 Mar; 121(3):226-32. PubMed ID: 17968514
[TBL] [Abstract][Full Text] [Related]
8. Chelation of vanadium(IV) by a natural and edible biopolymer poly(gamma-glutamic acid) in aqueous solution: structure and binding constant of complex.
Karmaker S; Saha TK
Macromol Biosci; 2008 Feb; 8(2):171-6. PubMed ID: 17941110
[TBL] [Abstract][Full Text] [Related]
9. A Zinc(II)/poly(gamma-glutamic acid) complex as an oral therapeutic for the treatment of type-2 diabetic KKAy mice.
Karmaker S; Saha TK; Yoshikawa Y; Sakurai H
Macromol Biosci; 2009 Mar; 9(3):279-86. PubMed ID: 18989849
[TBL] [Abstract][Full Text] [Related]
10. Hypoglycemic effect of macrocyclic binuclear oxovanadium (IV) complex on streptozotocin-induced diabetic rats.
Ramachandran B; Sekar DS; Kandaswamy M; Narayanan V; Subramanian S
Exp Diabesity Res; 2004; 5(2):137-42. PubMed ID: 15203884
[TBL] [Abstract][Full Text] [Related]
11. Investigation of a Cu(II)-poly(gamma-glutamic acid) complex in aqueous solution and its insulin-mimetic activity.
Karmaker S; Saha TK; Sakurai H
Macromol Biosci; 2007 Apr; 7(4):456-66. PubMed ID: 17429807
[TBL] [Abstract][Full Text] [Related]
12. Insulin mimetic effects of macrocyclic binuclear oxovanadium complexes on streptozotocin-induced experimental diabetes in rats.
Ramachandran B; Kandaswamy M; Narayanan V; Subramanian S
Diabetes Obes Metab; 2003 Nov; 5(6):455-61. PubMed ID: 14617232
[TBL] [Abstract][Full Text] [Related]
13. Vanadium and diabetes.
Poucheret P; Verma S; Grynpas MD; McNeill JH
Mol Cell Biochem; 1998 Nov; 188(1-2):73-80. PubMed ID: 9823013
[TBL] [Abstract][Full Text] [Related]
14. Polymer-phloridzin conjugates as an anti-diabetic drug that inhibits glucose absorption through the Na+/glucose cotransporter (SGLT1) in the small intestine.
Ikumi Y; Kida T; Sakuma S; Yamashita S; Akashi M
J Control Release; 2008 Jan; 125(1):42-9. PubMed ID: 18006167
[TBL] [Abstract][Full Text] [Related]
15. A new halogenated antidiabetic vanadyl complex, bis(5-iodopicolinato)oxovanadium(IV): in vitro and in vivo insulinomimetic evaluations and metallokinetic analysis.
Takino T; Yasui H; Yoshitake A; Hamajima Y; Matsushita R; Takada J; Sakurai H
J Biol Inorg Chem; 2001 Feb; 6(2):133-42. PubMed ID: 11293406
[TBL] [Abstract][Full Text] [Related]
16. Improvement of impaired glucose tolerance by oral administration of vanadyl sulfate by gavage in streptozotocin-induced diabetic rats.
Tsunajima T; Tatsuki R; Satoh K; Yamamoto A; Hoshi K; Ichihara K
Res Commun Mol Pathol Pharmacol; 1997 Nov; 98(2):190-200. PubMed ID: 9467827
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, spectroscopic, structural and thermal characterizations of vanadyl(IV) adenine complex prospective as antidiabetic drug agent.
El-Megharbel SM; Hamza RZ; Refat MS
Spectrochim Acta A Mol Biomol Spectrosc; 2015 Jan; 135():850-64. PubMed ID: 25150436
[TBL] [Abstract][Full Text] [Related]
18. An orally active antidiabetic vanadyl complex, bis(1-oxy-2-pyridinethiolato)oxovanadium(IV), with VO(S2O2) coordination mode; in vitro and in vivo evaluations in rats.
Sakurai H; Sano H; Takino T; Yasui H
J Inorg Biochem; 2000 May; 80(1-2):99-105. PubMed ID: 10885469
[TBL] [Abstract][Full Text] [Related]
19. A new candidate for insulinomimetic vanadium complex: synergism of oxovanadium(IV)porphyrin and sodium ascorbate.
Sakurai H; Inohara T; Adachi Y; Kawabe K; Yasui H; Takada J
Bioorg Med Chem Lett; 2004 Mar; 14(5):1093-6. PubMed ID: 14980642
[TBL] [Abstract][Full Text] [Related]
20. Structure-dependent metallokinetics of antidiabetic vanadyl-picolinate complexes in rats: studies on solution structure, insulinomimetic activity, and metallokinetics.
Yasui H; Tamura A; Takino T; Sakurai H
J Inorg Biochem; 2002 Jul; 91(1):327-38. PubMed ID: 12121792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
